“Promising” Trend: FDA Acts On Unapproved Drugs, Tainted Supplements

U.S. Marshals' seizure of unapproved erectile dysfunction drugs from Shangai Distributors may be evidence of a promising trend of FDA following through on warning letters to companies marketing unapproved new drugs mislabeled as supplements, according to food and drug attorney Marc Ullman